Document

Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on June 8, 2026, to discuss and provide rec...

PDF version FederalRegister.gov

Nuclear Regulatory Commission

AGENCY:

Nuclear Regulatory Commission.

ACTION:

Notice of meeting.

SUMMARY:

The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on June 8, 2026, to discuss and provide recommendations from the subcommittee on modernizing NRC regulations for byproduct material use of rulemaking. Topic is tentative based on its rulemaking schedule. Meeting information, including a copy of the agenda and handouts, will be available on the ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2026 or by emailing Ms. Sarah Hoenig at the contact information below.

DATES:

Date and Time for Open Session: June 8, 2026, from 12:30 p.m. to 2:00 p.m. EST.

Date	Webinar information (Microsoft teams)
June 8, 2026	Link: https://teams.microsoft.com/meet/293870212597451?p=zZIn45KWYAO8QvVhQP. Meeting ID: 293 870 212 597 451. Passcode: do7Xo2Lk.
	Call in number (audio only): +1 301-576-2978, United States, Silver Spring. Phone conference ID: 549 512 836#.

Public Participation: Any member of the public who wishes to participate in the meeting via Microsoft Teams or via phone should contact Ms. Sarah Hoenig using the information below.

FOR FURTHER INFORMATION CONTACT:

Ms. Sarah Hoenig, email: sarah.hoenig@nrc.gov phone: 301-415-3284.

SUPPLEMENTARY INFORMATION:

Purpose: Discuss recommendations from the subcommittee on modernizing NRC regulations for byproduct material use of rulemaking.

Conduct of the Meeting

The ACMUI Chair, Hossein Jadvar, M.D., Ph.D., will preside over the meeting.

Dr. Jadvar will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting:

1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Sarah Hoenig using the contact information listed above. All submittals must be received by the close of business on June 2, 2026, and must only pertain to the topics on the agenda.

2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the ACMUI Chair.

3. The draft transcript and meeting summary will be available on ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2026 on or about July 8, 2026.

4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Sarah Hoenig of their planned participation.

This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee ( printed page 29991) Act (5 U.S.C. App); and the Commission's regulations in Title 10 of the Code of Federal Regulations, Part 7.

Dated at Rockville, Maryland, this 19th day of May 2026.

For the U.S. Nuclear Regulatory Commission.

Russell E. Chazell,

Federal Advisory Committee Management Officer.

[FR Doc. 2026-10171 Filed 5-20-26; 8:45 am]

BILLING CODE 7590-01-P

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

91 FR 29990

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Advisory Committee on the Medical Uses of Isotopes: Meeting Notice,” thefederalregister.org (May 21, 2026), https://thefederalregister.org/documents/2026-10171/advisory-committee-on-the-medical-uses-of-isotopes-meeting-notice.